event,time
71 years old ,0
    woman ,0
    hypertension ,-2016
    ischaemic heart disease ,-2016
    peripheral vascular disease ,-2016
    unconscious state ,0
    head computed tomographic scan ,0
    stroke ,0
    condition deteriorated ,24
    inotropic support ,24
    septic shock ,24
    elevated erythrocyte sedimentation rate ,24
    elevated C-reactive protein ,24
    yeast in blood culture ,24
    caspofungin administered ,24
    death ,72
    yeast isolate Kw553/18 ,24
    VITEK 2 identification as Candida parapsilosis ,24
    CHROMagar Candida turquoise blue colonies ,24
    acetate ascospore agar ascospores ,24
    ribosomal DNA sequencing ,24
    antifungal susceptibility testing ,24
    amphotericin B MIC 0.012 ,24
    fluconazole MIC 0.125 ,24
    voriconazole MIC 0.004 ,24
    posaconazole MIC 0.003 ,24
    itraconazole MIC 0.008 ,24
    flucytosine MIC 0.064 ,24
    caspofungin MIC 0.064 ,24
    micafungin MIC 0.003 ,24
    no antibiotics ,0
    no central lines ,0
    hospitalized earlier for lower limb ischaemia ,-336
    discharge 2 weeks prior ,-336
    no risk factors ,0
    skin inoculation possibility ,0
    gastrointestinal translocation possibility ,0
    L. elongisporus bloodstream pathogen ,0
    virulence attributes unknown ,0
    environmental niche unknown ,0
    global prevalence ,0
    misidentification by VITEK 2 ,24
    turquoise blue colonies on CHROMagar ,24
    ascospore production ,24
    molecular identification required ,24
    reduced echinocandin susceptibility ,24
    Infectious Disease Society guidelines followed ,24
    caspofungin use ,24
    outcome death ,72
    rare yeast increased occurrence factors ,0
    selection pressure from antifungals ,0
    diagnostic challenges ,0
    higher mortality rates ,0
    no conflict of interest ,0
    technical support acknowledged ,0
